Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paltusotine vs placebo in acromegaly patients controlled on long-acting somatostatin receptor ligands
2020-005431-70Phase 3Active
- Sponsor
- Crinetics Pharmaceuticals
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acromegaly comparing Paltusotine with Placebo (2 arms). Primary endpoint: Proportion maintaining biochemical response in IGF-1 at End of Randomized Control Phase. Started May 2021; status: active.
02
Drugs
paltusotine
03
Conditions
acromegaly
Beyond the preview
Go deeper on 2020-005431-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005431-70.